506 related articles for article (PubMed ID: 24738483)
21. Aggressive combination drug therapy in very early polyarticular juvenile idiopathic arthritis (ACUTE-JIA): a multicentre randomised open-label clinical trial.
Tynjälä P; Vähäsalo P; Tarkiainen M; Kröger L; Aalto K; Malin M; Putto-Laurila A; Honkanen V; Lahdenne P
Ann Rheum Dis; 2011 Sep; 70(9):1605-12. PubMed ID: 21623000
[TBL] [Abstract][Full Text] [Related]
22. The outcomes of juvenile idiopathic arthritis in children managed with contemporary treatments: results from the ReACCh-Out cohort.
Guzman J; Oen K; Tucker LB; Huber AM; Shiff N; Boire G; Scuccimarri R; Berard R; Tse SM; Morishita K; Stringer E; Johnson N; Levy DM; Duffy KW; Cabral DA; Rosenberg AM; Larché M; Dancey P; Petty RE; Laxer RM; Silverman E; Miettunen P; Chetaille AL; Haddad E; Houghton K; Spiegel L; Turvey SE; Schmeling H; Lang B; Ellsworth J; Ramsey S; Bruns A; Campillo S; Benseler S; Chédeville G; Schneider R; Yeung R; Duffy CM;
Ann Rheum Dis; 2015 Oct; 74(10):1854-60. PubMed ID: 24842571
[TBL] [Abstract][Full Text] [Related]
23. Juvenile idiopathic arthritis--current and future therapies.
Kahn P
Bull NYU Hosp Jt Dis; 2009; 67(3):291-302. PubMed ID: 19852753
[TBL] [Abstract][Full Text] [Related]
24. Juvenile idiopathic arthritis - what the clinician needs to know.
Kahn PJ
Bull Hosp Jt Dis (2013); 2013; 71(3):194-9. PubMed ID: 24151944
[TBL] [Abstract][Full Text] [Related]
25. Treatment of non-systemic juvenile idiopathic arthritis.
Shenoi S; Horneff G; Aggarwal A; Ravelli A
Nat Rev Rheumatol; 2024 Mar; 20(3):170-181. PubMed ID: 38321298
[TBL] [Abstract][Full Text] [Related]
26. Feasibility and efficacy of intraarticular steroids (IAS) in juvenile idiopathic arthritis (JIA).
Verma S; Gupta R; Lodha R; Kabra SK
Indian Pediatr; 2009 Mar; 46(3):264-5. PubMed ID: 19346579
[TBL] [Abstract][Full Text] [Related]
27. [Guidelines on biologic drugs for the treatment of children with juvenile idiopathic arthritis (JIA)].
Bukovac LT; Vidović M; Lamot L; Perica M; Harjacek M;
Reumatizam; 2013; 60(1):57-66. PubMed ID: 24003687
[TBL] [Abstract][Full Text] [Related]
28. Development of germinoma during the treatment of systemic-onset juvenile idiopathic arthritis with infliximab.
Takezaki S; Okura Y; Ichikawa M; Suzuki D; Ohshima J; Kaneda M; Cho Y; Yamada M; Kawamura N; Iguchi A; Kobayashi I; Ariga T
Mod Rheumatol; 2012 Aug; 22(4):621-4. PubMed ID: 22072226
[TBL] [Abstract][Full Text] [Related]
29. High doses of infliximab in the management of juvenile idiopathic arthritis.
Tambralli A; Beukelman T; Weiser P; Atkinson TP; Cron RQ; Stoll ML
J Rheumatol; 2013 Oct; 40(10):1749-55. PubMed ID: 23950184
[TBL] [Abstract][Full Text] [Related]
30. Management of Juvenile Idiopathic Arthritis: A Clinical Guide.
Blazina Š; Markelj G; Avramovič MZ; Toplak N; Avčin T
Paediatr Drugs; 2016 Dec; 18(6):397-412. PubMed ID: 27484749
[TBL] [Abstract][Full Text] [Related]
31. Systemic Juvenile Idiopathic Arthritis Complicated by Macrophage Activation Syndrome.
Wagner-Weiner L
Pediatr Ann; 2015 Jun; 44(6):e142-7. PubMed ID: 26114369
[TBL] [Abstract][Full Text] [Related]
32. Beyond the guidelines management of juvenile idiopathic arthritis: a case report of a girl with polyarticular disease refractory to multiple treatment options and Leri Weill syndrome.
Vukić V; Smajo A; Vidović M; Vukojević R; Harjaček M; Lamot L
BMC Pediatr; 2021 Jan; 21(1):40. PubMed ID: 33451288
[TBL] [Abstract][Full Text] [Related]
33. Novel treatment options for juvenile idiopathic arthritis.
Steigerwald KA; Ilowite NT
Expert Rev Clin Pharmacol; 2015; 8(5):559-73. PubMed ID: 26294075
[TBL] [Abstract][Full Text] [Related]
34. Treatment of juvenile idiopathic arthritis: a revolution in care.
Stoll ML; Cron RQ
Pediatr Rheumatol Online J; 2014; 12():13. PubMed ID: 24782683
[TBL] [Abstract][Full Text] [Related]
35. Outcome and Trends in Treatment of Systemic Juvenile Idiopathic Arthritis in the German National Pediatric Rheumatologic Database, 2000-2013.
Klotsche J; Raab A; Niewerth M; Sengler C; Ganser G; Kallinich T; Niehues T; Hufnagel M; Thon A; Hospach T; Horneff G; Minden K
Arthritis Rheumatol; 2016 Dec; 68(12):3023-3034. PubMed ID: 27332999
[TBL] [Abstract][Full Text] [Related]
36. Life-threatening pneumonitis complicating low-dose methotrexate treatment for juvenile idiopathic arthritis in a child.
Liu YC; Tu YL; Wu RC; Huang JL; Yao TC
Pediatr Emerg Care; 2014 Jun; 30(6):415-7. PubMed ID: 24892681
[TBL] [Abstract][Full Text] [Related]
37. The role of synthetic drugs in the biologic era: therapeutic strategies for treating juvenile idiopathic arthritis.
Hügle B; Horneff G
Expert Opin Pharmacother; 2016; 17(5):703-14. PubMed ID: 26678914
[TBL] [Abstract][Full Text] [Related]
38. Treatment of patients with juvenile idiopathic arthritis (JIA) in a population-based cohort.
Zamora-Legoff JA; Krause ML; Crowson CS; Muskardin TW; Mason T; Matteson EL
Clin Rheumatol; 2016 Jun; 35(6):1493-9. PubMed ID: 26825065
[TBL] [Abstract][Full Text] [Related]
39. Systemic-onset juvenile idiopathic arthritis: the changing life of a rare disease.
Cimaz R; Von Scheven A; Hofer M
Swiss Med Wkly; 2012; 142():w13582. PubMed ID: 22573189
[TBL] [Abstract][Full Text] [Related]
40. Decreased expression of nicotinamide phosphoribosyltransferase in patients with juvenile idiopathic arthritis receiving methotrexate.
Fox EJ; Leeder JS; Ye SQ; Becker ML
J Rheumatol; 2013 May; 40(5):741-2. PubMed ID: 23637381
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]